Sartorius Stedim Biotech S.A./€DIM

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A. specializes in providing equipment and services for the biopharmaceutical industry, focusing on products such as cell lines, cell culture media, bioreactors, and systems for separation, purification, and storage of biological products. Founded in 1978 and headquartered in Aubagne, France, the company operates globally with manufacturing and R&D sites in Europe, North America, and Asia. A subsidiary of Sartorius AG, Sartorius Stedim Biotech has expanded its portfolio through acquisitions, including the 2023 purchase of Polyplus-transfection SA for $2.7 billion. In 2023, the company reported sales revenue of approximately €2.8 billion and employed over 10,600 individuals worldwide. (,)

Ticker

€DIM

Primary listing

PAR

Employees

10,030

DIM Metrics

BasicAdvanced
€17B
73.56
€2.31
0.93
€0.69
0.41%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €DIM

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs